Galderma Investigational Therapy Nemolizumab Granted FDA Breakthrough Therapy Designation for the Treatment of Patients Suffering from Prurigo Nodularis

WVNews | Business

Dec 9, 2019

LAUSANNE, Switzerland--(BUSINESS WIRE)--Dec 9, 2019--